Dual Mobility for Oncological Hip Reconstruction: Significantly Reduced Dislocation Rates at 5 years

CONCLUSIONS: DMs showed markedly lower rates of dislocation than conventional THAs, with overall revision rates remaining comparable among different designs. DMs should be considered the option of choice for oncological hip reconstruction if compared with conventional THAs. HAs are a feasible alternative when encountering femoral disease involvement only.LEVEL OF EVIDENCE: III.PMID:38052029 | DOI:10.5435/JAAOS-D-23-00608

Source: The Journal of the American Academy of Orthopaedic Surgeons - December 5, 2023 Category: Orthopaedics Authors: Daniel Karczewski Marcos R Gonzalez Angad Bedi Erik Newman Kevin Raskin Megan E Anderson Santiago A Lozano-Calderon Source Type: research